(Q61957102)
Statements
A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Study the Safety and Insulin-Sparing Efficacy of the Addition of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Insulin Alone or in Combination With Metformin (English)
0 references
13 January 2012
0 references
6 June 2013
0 references
660
0 references
18 year
0 references
80 year
0 references